Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 24 von 89
Journal of clinical epidemiology, 2008-04, Vol.61 (4), p.365-372
2008
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios
Ist Teil von
  • Journal of clinical epidemiology, 2008-04, Vol.61 (4), p.365-372
Ort / Verlag
New York, NY: Elsevier Inc
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
  • Abstract Objective To study the odds ratio (OR) as measure of treatment effect in the context of mutually exclusive causes of death. Study Design and Setting As example we consider meta-analyses of randomized trials of implantable cardioverter defibrillator implantation (ICD). We compare the pooled OR to the pooled cause-specific hazard ratio (HR) for each of the mutually exclusive outcomes “sudden cardiac death” (SCD) and “death other than SCD.” Results The pooled OR and cause-specific HR for the reduction of SCD are similar (0.43 and 0.44, respectively) for nine included trials. However, the OR erroneously presumes a potential trend toward an adverse effect of the ICD on “death other than arrhythmia” (OR 1.11 [0.84–1.45]), whereas such an effect is small with the cause-specific HR (HR 1.03 [0.79–1.32]). In general, it is shown that a spurious association of treatment with “other death” may be seen when a substantial number of death from the cause of interest is postponed. Conclusion The OR should be used with caution to study effects of treatment on mutually exclusive causes of death. Practically this concern applies primarily to meta-analysis where the use of the cause-specific HR, whenever available, is recommended.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX